Catinazzo Thomas (CIK 1818261) reported 30 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-08). Recent activity: Sell RLAY (17,717 shares), Sell RLAY (17,717 shares), Buy RLAY (56,323 shares), Sell RLAY (56,323 shares), Buy RLAY (61,563 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-08 | Relay Therapeutics, Inc. (RLAY) | Chief Financial Officer | Sell | 17,717 | $331,131 |
| 2026-06-24 | Relay Therapeutics, Inc. (RLAY) | Chief Financial Officer | Sell | 17,717 | $301,366 |
| 2026-06-24 | Relay Therapeutics, Inc. (RLAY) | Chief Financial Officer | Buy | 56,323 | $283,868 |
| 2026-06-24 | Relay Therapeutics, Inc. (RLAY) | Chief Financial Officer | Sell | 56,323 | $955,801 |
| 2026-06-24 | Relay Therapeutics, Inc. (RLAY) | Chief Financial Officer | Buy | 61,563 | $321,359 |
| 2026-06-24 | Relay Therapeutics, Inc. (RLAY) | Chief Financial Officer | Sell | 61,563 | $1.0M |
| 2026-06-24 | Relay Therapeutics, Inc. (RLAY) | Chief Financial Officer | Buy | 51,560 | $229,442 |
| 2026-06-24 | Relay Therapeutics, Inc. (RLAY) | Chief Financial Officer | Sell | 51,560 | $874,973 |
| 2026-05-14 | Relay Therapeutics, Inc. (RLAY) | Chief Financial Officer | Sell | 17,717 | $227,841 |
| 2026-04-30 | Relay Therapeutics, Inc. (RLAY) | Chief Financial Officer | Sell | 972 | $14,376 |
| 2026-04-09 | Relay Therapeutics, Inc. (RLAY) | Chief Financial Officer | Sell | 1,800 | $27,000 |
| 2026-04-09 | Relay Therapeutics, Inc. (RLAY) | Chief Financial Officer | Buy | 1,800 | $9,396 |
| 2026-04-09 | Relay Therapeutics, Inc. (RLAY) | Chief Financial Officer | Sell | 17,717 | $230,498 |
| 2026-03-11 | Relay Therapeutics, Inc. (RLAY) | Chief Financial Officer | Sell | 17,717 | $178,233 |
| 2026-01-29 | Relay Therapeutics, Inc. (RLAY) | Chief Financial Officer | Sell | 13,820 | $105,308 |
| 2026-01-29 | Relay Therapeutics, Inc. (RLAY) | Chief Financial Officer | Sell | 1,695 | $14,323 |
| 2025-10-30 | Relay Therapeutics, Inc. (RLAY) | Chief Financial Officer | Sell | 21,664 | $157,931 |
| 2025-07-30 | Relay Therapeutics, Inc. (RLAY) | Chief Financial Officer | Sell | 1,701 | $6,362 |
| 2025-07-30 | Relay Therapeutics, Inc. (RLAY) | Chief Financial Officer | Sell | 18,380 | $67,638 |
| 2025-04-30 | Relay Therapeutics, Inc. (RLAY) | Chief Financial Officer | Sell | 1,709 | $5,418 |
| 2025-04-30 | Relay Therapeutics, Inc. (RLAY) | Chief Financial Officer | Sell | 981 | $3,110 |
| 2025-04-30 | Relay Therapeutics, Inc. (RLAY) | Chief Financial Officer | Sell | 3,558 | $11,492 |
| 2025-04-30 | Relay Therapeutics, Inc. (RLAY) | Chief Financial Officer | Sell | 12,943 | $38,829 |
| 2025-03-31 | Relay Therapeutics, Inc. (RLAY) | Chief Financial Officer | Sell | 298 | $846 |
| 2025-03-31 | Relay Therapeutics, Inc. (RLAY) | Chief Financial Officer | Sell | 4,566 | $12,967 |
Source: SEC Form 4 filings · as of 2026-07-08